Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

21.33 -0.24 (-1.11%)
Streaming Delayed Price Updated: 10:55 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Fulgent (FLGT) Q2 Revenue Jumps 16%
Via The Motley Fool
Why Fulgent Genetics Stock Was Crushing It on Friday
The next-generation diagnostics specialist had a beat-and-raise second quarter. 
Via The Motley Fool
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
These stocks that are showing activity before the opening bell on Friday.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Fulgent Genetics Earnings Preview
Via Benzinga
A Peek at Fulgent Genetics's Future Earnings
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For August 1, 2025
 
Via Benzinga
Uncovering Potential: Fulgent Genetics's Earnings Preview
 
Via Benzinga
Earnings Preview: Fulgent Genetics
 
Via Benzinga
Why Is Fulgent Genetics Stock Moving Higher Today?
Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.< 
Via Benzinga
Earnings Scheduled For May 2, 2025
 
Via Benzinga
Fulgent Genetics Revenue Tops Estimates
Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss. 
Via The Motley Fool
Earnings Scheduled For February 28, 2025
 
Via Benzinga
Earnings Outlook For Fulgent Genetics
 
Via Benzinga
FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024
FLGT stock results show that Fulgent Genetics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
The 3 Best Digital Health Stocks for Personalized Medicine
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health. 
Via InvestorPlace
Earnings Scheduled For November 3, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
Fulgent Genetics Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Fulgent Genetics: Q1 Earnings Insights
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Earnings Scheduled For August 4, 2023
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter. 
Via Benzinga
Preview: Fulgent Genetics's Earnings
 
Via Benzinga
Looking Into Fulgent Genetics's Return On Capital Employed
 
Via Benzinga
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist
Fulgent is moving past its pandemic-era business, and that's a good thing. 
Via The Motley Fool
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
Neither has a traditional business model, but that could be an asset for both. 
Via The Motley Fool
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
Both are experiencing a bit of a hangover from declining COVID-19-related sales. 
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
7 Stocks to Buy to Bag Big-Time Returns in Q2
If you’re willing to take huge risks, these stocks to buy might yield you massive gains in Q2 – or you could be looking at a tax write-off. 
Via InvestorPlace
Earnings Scheduled For May 5, 2023
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.